Anixa Biosciences Inc (ANIX): who owns it and who trades it
As of Nov 16, 2026, ANIX insiders reported 21 purchases worth $522K in the last 12 months. The largest buyer was Lewis H Titterton jr (Director), with $241K. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Anixa Biosciences
From the latest filingsOverall: more buying than selling. Funds and insiders mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ANIX
62 funds and institutions reported ANIX shares worth $15M at the end of Q2 2026, about 16% of the company. The largest holder is Vanguard Capital Management LLC with 3.9%.
Funds and institutions (13F) 16%Everyone else 84%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.33M | 3.91% | $3.7M | +1% |
| UBS Group AG | 585,430 | 1.72% | $1.6M | +6% |
| Laird Norton Wetherby Trust Company, LLC | 578,727 | 1.70% | $1.6M | +2% |
| D.a. Davidson & Co. | 539,272 | 1.59% | $1.5M | No change |
| Geode Capital Management, LLC | 359,194 | 1.06% | $1M | -2% |
| Marshall Wace, LLP | 328,332 | 0.97% | $919K | +90% |
| BlackRock, Inc. | 199,755 | 0.59% | $559K | +17% |
| Vanguard Fiduciary Trust Co | 192,356 | 0.57% | $539K | +1% |
| State Street Corp | 159,040 | 0.47% | $445K | No change |
| Gsa Capital Partners LLP | 117,465 | 0.35% | $329K | +19% |
| LPL Financial LLC | 111,535 | 0.33% | $312K | +38% |
| Northern Trust Corp | 69,235 | 0.20% | $194K | +4% |
| Renaissance Technologies LLC | 59,373 | 0.17% | $166K | -3% |
| CoreCap Advisors, LLC | 52,020 | 0.15% | $146K | No change |
| Bank of New York Mellon Corp | 47,442 | 0.14% | $133K | No change |
| Westside Investment Management, Inc. | 43,000 | 0.13% | $120K | -9% |
| HighTower Advisors, LLC | 41,150 | 0.12% | $115K | -1% |
| Kestra Advisory Services, LLC | 38,000 | 0.11% | $106K | -25% |
| Corient Private Wealth LP | 37,400 | 0.11% | $105K | +87% |
| Gemmer Asset Management LLC | 35,000 | 0.10% | $98K | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ANIX insiders reported $522K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $3.17 | $15.8K | Form 4 |
| Oct 23, 2026 | Lewis H Titterton jr | Director | Purchase | 8,000 | $2.98 | $23.8K | Form 4 |
| Oct 22, 2026 | Amit Kumar | CEO | Purchase | 8,000 | $2.72 | $21.8K | Form 4 |
| Sep 30, 2026 | Michael Catelani | CFO | Purchase | 5,500 | $2.84 | $15.6K | Form 4 |
| Sep 24, 2026 | Amit Kumar | CEO | Purchase | 7,000 | $2.78 | $19.5K | Form 4 |
| Sep 24, 2026 | Arnold M Baskies | Director | Purchase | 5,000 | $2.76 | $13.8K | Form 4 |
| Sep 23, 2026 | Lewis H Titterton jr | Director | Purchase | 49,036 | $2.69 | $132K | Form 4 |
| Sep 10, 2026 | Amit Kumar | CEO | Purchase | 3,000 | $2.75 | $8.2K | Form 4 |
| Sep 10, 2026 | Lewis H Titterton jr | Director | Purchase | 10,000 | $2.73 | $27.3K | Form 4 |
| Sep 10, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $2.76 | $13.8K | Form 4 |
| Jul 31, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $3.47 | $17.4K | Form 4 |
| Jul 27, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $3.44 | $17.2K | Form 4 |
| Jul 27, 2026 | Amit Kumar | CEO | Purchase | 3,188 | $3.37 | $10.7K | Form 4 |
| Jul 24, 2026 | Amit Kumar | CEO | Purchase | 3,000 | $3.73 | $11.2K | Form 4 |
| Jul 20, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $3.46 | $17.3K | Form 4 |
| Jul 20, 2026 | Lewis H Titterton jr | Director | Purchase | 12,000 | $3.47 | $41.6K | Form 4 |
| Jul 15, 2026 | Lewis H Titterton jr | Director | Purchase | 2,797 | $3.28 | $9.2K | Form 4 |
| Jul 10, 2026 | Amit Kumar | CEO | Purchase | 5,000 | $3.04 | $15.2K | Form 4 |
| Jun 16, 2026 | Lewis H Titterton jr | Director | Purchase | 2,836 | $2.64 | $7.5K | Form 4 |
| Jun 12, 2026 | Amit Kumar | CEO | Purchase | 21,000 | $2.50 | $52.5K | Form 4 |
| Jan 28, 2026 | Arnold M Baskies | Director | Purchase | 10,000 | $3.04 | $30.4K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Lewis H Titterton jr | Director | $241K | – | Oct 23, 2026 |
| Amit Kumar | Chief Executive Officer, Director | $221K | – | Oct 30, 2026 |
| Arnold M Baskies | Director | $44.2K | – | Sep 24, 2026 |
| Michael Catelani | President, COO, & CFO | $15.6K | – | Sep 30, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ANIX short interest
Low short interest. 4.7% of ANIX shares are sold short: about 1 share in 21. Over the last 12 reports the number of shares short went up 66%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.63M ANIX shares were sold short, 4.7% of the shares outstanding, down 2.0% from the report before. At the average daily volume of 193,792 shares, buying them all back would take about 8.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.63M | 4.68% | -2% | 193,792 | 8.4 |
| Oct 15, 2026 | 1.66M | 4.78% | +23% | 260,145 | 6.4 |
| Sep 30, 2026 | 1.35M | 3.88% | +28% | 366,181 | 3.7 |
| Sep 15, 2026 | 1.05M | 3.03% | +6% | 387,429 | 2.7 |
| Aug 31, 2026 | 993,183 | 2.92% | +2% | 297,810 | 3.3 |
| Aug 14, 2026 | 977,973 | 2.87% | -10% | 154,795 | 6.3 |
| Jul 31, 2026 | 1.09M | 3.21% | +27% | 297,631 | 3.7 |
| Jul 15, 2026 | 862,186 | 2.53% | -3% | 277,050 | 3.1 |
| Jun 30, 2026 | 885,939 | 2.60% | +10% | 366,306 | 2.4 |
| Jun 15, 2026 | 803,102 | 2.36% | -21% | 132,292 | 6.1 |
| May 29, 2026 | 1.01M | 3.02% | +3% | 93,641 | 10.8 |
| May 15, 2026 | 983,354 | 2.93% | -5% | 113,131 | 8.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Anixa Biosciences company events
Anixa Biosciences filed 3 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Mar 11, 2026.
- Mar 11, 2026VoteReported shareholder vote results. Filing
- Feb 9, 2026AnnouncementShared information with investors. Filing
- Dec 12, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Anixa Biosciences financials
Famous investors that hold ANIX
2 of the 50 well-known investors we track reported holding ANIX in their latest 13F filing. The largest position is Jim Simons's, worth $881K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 300,550 | $881K | 0.0% | +406% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 19,961 | $58.5K | 0.0% | -37% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Anixa Biosciences Inc (ANIX) stock
Who owns the most ANIX stock?
The largest reported owner of Anixa Biosciences Inc (ANIX) is Vanguard Capital Management LLC, with 3.9% of the company. In total, 62 funds and institutions reported holding ANIX at the end of Q2 2026, together about 16% of the shares. See the largest owners.
Are ANIX insiders buying or selling?
In the last 12 months, ANIX insiders reported 21 open-market purchases worth $522K and no sales. The latest trade was on Oct 30, 2026. See every trade.
What is the short interest in ANIX?
As of Oct 30, 2026, 1.63M ANIX shares were sold short, 4.7% of the shares outstanding, down 2.0% from the report before. At the average daily volume of 193,792 shares, buying them all back would take about 8.4 trading days (days to cover). See the history.
Which famous investors hold ANIX?
2 of the 50 well-known investors we track reported ANIX in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $881K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.